Moreover, by inhibiting miR-21 and up-regulating Smad7 expression, the activation of p-Smad2 and p-Smad3 pathways in the hearts of T1DM mice could be blocked, thereby inhibiting EndMT activation and cardiac fibrosis (Li et al., 2020b). Here, SMAD3 is linked to type 1 diabetes mellitus.